(WLY) John Wiley & Sons - Ratings and Ratios
Research, Journals, Books, Courseware, Assessment
Dividends
| Dividend Yield | 4.57% |
| Yield on Cost 5y | 3.85% |
| Yield CAGR 5y | 0.72% |
| Payout Consistency | 95.0% |
| Payout Ratio | 37.2% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 38.0% |
| Value at Risk 5%th | 54.7% |
| Relative Tail Risk | -12.57% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.99 |
| Alpha | -39.91 |
| CAGR/Max DD | -0.10 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.489 |
| Beta | 0.525 |
| Beta Downside | 0.411 |
| Drawdowns 3y | |
|---|---|
| Max DD | 39.89% |
| Mean DD | 19.68% |
| Median DD | 21.70% |
Description: WLY John Wiley & Sons November 10, 2025
John Wiley & Sons (NYSE:WLY) is a long-standing publisher that delivers authoritative content and data-driven knowledge services across science, innovation, and learning markets in the United States, China, the United Kingdom, Japan, Australia, and globally. Its two primary divisions are the Research segment-selling scientific, technical, medical, and scholarly journals to libraries, societies, and researchers-and the Learning segment-offering print and digital textbooks, courseware, and assessment tools to students, educators, and professional audiences through both brick-and-mortar and online channels.
In FY2023 Wiley generated roughly $1.7 billion in revenue, with digital subscription revenue growing about 12% year-over-year, reflecting the broader industry shift toward online research and e-learning platforms. Operating margins have been pressured by rising content acquisition costs and inflationary labor expenses, while the company’s exposure to university enrollment trends and corporate training budgets remains a key economic driver for the Learning segment. Additionally, Wiley’s international expansion-particularly in China and the UK-provides a diversification hedge against domestic market slowdown.
If you’re looking to deepen your quantitative analysis of Wiley’s valuation metrics, ValueRay offers a free, data-rich dashboard that can help you benchmark the stock against peers and track the drivers highlighted above.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (101.7m TTM) > 0 and > 6% of Revenue (6% = 99.9m TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA 1.79pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -9.55% (prev -10.86%; Δ 1.31pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.09 (>3.0%) and CFO 220.1m > Net Income 101.7m (YES >=105%, WARN >=100%) |
| Net Debt (897.2m) to EBITDA (342.3m) ratio: 2.62 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.71 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (53.5m) change vs 12m ago -2.43% (target <= -2.0% for YES) |
| Gross Margin 71.13% (prev 70.28%; Δ 0.85pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 65.64% (prev 67.45%; Δ -1.81pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.06 (EBITDA TTM 342.3m / Interest Expense TTM 48.0m) >= 6 (WARN >= 3) |
Altman Z'' 2.96
| (A) -0.06 = (Total Current Assets 381.2m - Total Current Liabilities 540.4m) / Total Assets 2.47b |
| (B) 0.65 = Retained Earnings (Balance) 1.61b / Total Assets 2.47b |
| (C) 0.08 = EBIT TTM 194.8m / Avg Total Assets 2.54b |
| (D) 0.70 = Book Value of Equity 1.21b / Total Liabilities 1.73b |
| Total Rating: 2.96 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 57.50
| 1. Piotroski 6.50pt |
| 2. FCF Yield 5.66% |
| 3. FCF Margin 8.91% |
| 4. Debt/Equity 0.39 |
| 5. Debt/Ebitda 2.62 |
| 6. ROIC - WACC (= 4.22)% |
| 7. RoE 8.78% |
| 8. Rev. Trend -87.08% |
| 9. EPS Trend 4.23% |
What is the price of WLY shares?
Over the past week, the price has changed by -4.51%, over one month by -16.60%, over three months by -24.19% and over the past year by -30.33%.
Is WLY a buy, sell or hold?
- Strong Buy: 0
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the WLY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 60 | 93.9% |
| Analysts Target Price | 60 | 93.9% |
| ValueRay Target Price | 30.7 | -0.7% |
WLY Fundamental Data Overview December 07, 2025
P/E Trailing = 18.2022
P/E Forward = 10.8342
P/S = 1.0348
P/B = 2.7499
P/EG = 2.4803
Beta = 1.024
Revenue TTM = 1.67b USD
EBIT TTM = 194.8m USD
EBITDA TTM = 342.3m USD
Long Term Debt = 789.4m USD (from longTermDebt, last fiscal year)
Short Term Debt = 26.6m USD (from shortTermDebt, last quarter)
Debt = 964.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 897.2m USD (from netDebt column, last quarter)
Enterprise Value = 2.62b USD (1.72b + Debt 964.6m - CCE 67.4m)
Interest Coverage Ratio = 4.06 (Ebit TTM 194.8m / Interest Expense TTM 48.0m)
FCF Yield = 5.66% (FCF TTM 148.3m / Enterprise Value 2.62b)
FCF Margin = 8.91% (FCF TTM 148.3m / Revenue TTM 1.67b)
Net Margin = 6.11% (Net Income TTM 101.7m / Revenue TTM 1.67b)
Gross Margin = 71.13% ((Revenue TTM 1.67b - Cost of Revenue TTM 480.9m) / Revenue TTM)
Gross Margin QoQ = 72.11% (prev 72.46%)
Tobins Q-Ratio = 1.06 (Enterprise Value 2.62b / Total Assets 2.47b)
Interest Expense / Debt = 1.21% (Interest Expense 11.7m / Debt 964.6m)
Taxrate = 22.62% (13.1m / 58.0m)
NOPAT = 150.8m (EBIT 194.8m * (1 - 22.62%))
Current Ratio = 0.71 (Total Current Assets 381.2m / Total Current Liabilities 540.4m)
Debt / Equity = 0.39 (Debt 964.6m / totalStockholderEquity, last quarter 2.47b)
Debt / EBITDA = 2.62 (Net Debt 897.2m / EBITDA 342.3m)
Debt / FCF = 6.05 (Net Debt 897.2m / FCF TTM 148.3m)
Total Stockholder Equity = 1.16b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.12% (Net Income 101.7m / Total Assets 2.47b)
RoE = 8.78% (Net Income TTM 101.7m / Total Stockholder Equity 1.16b)
RoCE = 10.00% (EBIT 194.8m / Capital Employed (Equity 1.16b + L.T.Debt 789.4m))
RoIC = 9.65% (NOPAT 150.8m / Invested Capital 1.56b)
WACC = 5.43% (E(1.72b)/V(2.69b) * Re(7.95%) + D(964.6m)/V(2.69b) * Rd(1.21%) * (1-Tc(0.23)))
Discount Rate = 7.95% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -81.65 | Cagr: -0.90%
[DCF Debug] Terminal Value 75.50% ; FCFE base≈133.1m ; Y1≈112.1m ; Y5≈84.3m
Fair Price DCF = 34.79 (DCF Value 1.55b / Shares Outstanding 44.4m; 5y FCF grow -19.13% → 3.0% )
EPS Correlation: 4.23 | EPS CAGR: 3.99% | SUE: 0.57 | # QB: 0
Revenue Correlation: -87.08 | Revenue CAGR: -5.23% | SUE: 0.14 | # QB: 0
EPS next Quarter (2026-01-31): EPS=0.86 | Chg30d=-0.170 | Revisions Net=+1 | Analysts=1
EPS current Year (2026-04-30): EPS=4.00 | Chg30d=+0.000 | Revisions Net=+1 | Growth EPS=+9.9% | Growth Revenue=-1.0%
EPS next Year (2027-04-30): EPS=4.40 | Chg30d=+0.000 | Revisions Net=+1 | Growth EPS=+10.0% | Growth Revenue=+2.3%
Additional Sources for WLY Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle